Table 1. Patient characteristics.
| Characteristics | BVZ Cohort | CCNU/VM26 Cohort |
|---|---|---|
| n | 30 | 9 |
| Sex | ||
| • Female | 8 | 3 |
| • Male | 22 | 6 |
| Age | ||
| • Median (range) | 52 (31–69) | 57 (48–66) |
| Histology | ||
| • Primary GBM | 26 | 8 |
| • Secondary GBM | 4 | 1 |
| Previous therapies | ||
| • No. of surgeries, median (range) | 1 (0–4) | 1 (0–3) |
| • No. of radiotherapies, median (range) | 1 (1–4) | 1 (1–2) |
| • No. of chemotherapies, median (range) | 2 (1–6) | 2 (1–2) |
| Recurrences | ||
| • Median (range) | 3 (1–5) | 2 (1–3) |
| Concomitant therapy | ||
| • Irinotecan | 6 | n/a |
| • Topotecan | 1 | n/a |
| • Radiotherapy | 5 | n/a |
Patient characteristics, pretreatments and concomitant therapies for all patients in the BVZ cohort as well as the CCNU/VM26 cohort.